East Windsor, NJ, United States of America

Hartmuth C Kolb

USPTO Granted Patents = 13 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • East Windsor, NY (US) (2003)
  • East Windsor, NJ (US) (2002 - 2004)
  • Marina Del Rey, CA (US) (2007)
  • San Diego, CA (US) (2005 - 2024)

Company Filing History:


Years Active: 2002-2024

Loading Chart...
13 patents (USPTO):Explore Patents

Title: Hartmuth C Kolb: Innovator in Tau PET Imaging Ligands

Introduction

Hartmuth C Kolb is a prominent inventor based in East Windsor, NJ (US), known for his significant contributions to the field of medical imaging. He holds a total of 13 patents, showcasing his innovative spirit and dedication to advancing technology in healthcare.

Latest Patents

Among his latest inventions are novel, selective radiolabelled tau ligands that are instrumental in imaging and quantifying tau aggregates using positron-emission tomography (PET). These tau PET imaging ligands are designed to enhance the understanding of tau pathology in various neurodegenerative diseases. The invention also encompasses compositions that include these compounds, processes for their preparation, and their application for imaging tissues or subjects, both in vitro and in vivo.

Career Highlights

Throughout his career, Hartmuth has worked with notable companies such as Lexicon Pharmaceuticals, Inc. and Janssen Pharmaceutica NV. His work in these organizations has contributed to the development of innovative solutions in the pharmaceutical and medical imaging sectors.

Collaborations

Hartmuth has collaborated with esteemed colleagues, including Zhi-Cai Shi and Ramanaiah C Kanamarlapudi, further enhancing the impact of his research and inventions.

Conclusion

Hartmuth C Kolb's contributions to the field of tau PET imaging ligands exemplify his commitment to innovation in medical technology. His work continues to influence advancements in imaging techniques, ultimately benefiting the understanding and treatment of neurodegenerative diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…